Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de ARS Pharmaceuticals Inc?

Accepted Answer

Según el último estado financiero (Form-10K), ARS Pharmaceuticals Inc tiene un total de activos de $351, una ganancia neta profit de $7

Question 2

¿Cuáles son los ratios financieros clave para SPRY?

Accepted Answer

El ratio corriente de ARS Pharmaceuticals Inc es 3.73, el margen neto es 7.86, las ventas por acción son $0.86.

Question 3

¿Cómo se desglosan los ingresos de ARS Pharmaceuticals Inc por segmento o geografía?

Accepted Answer

ARS Pharmaceuticals Inc largest revenue segment is Needle-free Intranasal, at a revenue of 30,000 in the most earnings release.For geography, United States is the primary market for ARS Pharmaceuticals Inc, at a revenue of 30,000.

Question 4

¿Es rentable ARS Pharmaceuticals Inc?

Accepted Answer

yes, según los últimos estados financieros, ARS Pharmaceuticals Inc tiene una ganancia neta profit de $7

Question 5

¿Tiene ARS Pharmaceuticals Inc alguna deuda?

Accepted Answer

yes, ARS Pharmaceuticals Inc tiene una deuda de 94

Question 6

¿Cuántas acciones en circulación tiene ARS Pharmaceuticals Inc?

Accepted Answer

ARS Pharmaceuticals Inc tiene un total de acciones en circulación de 97.95

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	112	89	0	1	0	0
Revenue Growth (YoY)	--	--	-100%	--	--	--
Cost of Revenue	7	0	--	--	--	--
Gross Profit	105	88	--	--	--	--
Selling, General & Admin	150	71	47	18	28	8
Research & Development	14	19	20	18	61	24
Operating Expenses	164	91	67	36	89	32
Other Non Operating Income (Expenses)	11	11	13	1	--	--
Pretax Income	-47	8	-54	-34	-89	-32
Income Tax Expense	--	0	--	--	--	--
Net Income	-48	7	-54	-34	-89	-32
Net Income Growth	9%	-112.99%	59%	-62%	178%	39%
Shares Outstanding (Diluted)	98.36	102.39	95.21	39.96	34.93	34.7
Shares Change (YoY)	2%	8%	138%	14%	1%	5%
EPS (Diluted)	-0.48	0.07	-0.57	-0.87	-2.56	-0.95
EPS Growth	2%	-113.99%	-34%	-66%	169%	32%
Free Cash Flow	-53	12	-59	-40	-68	-32
Free Cash Flow Per Share	-0.53	0.11	-0.61	-1	-1.94	-0.92
Gross Margin	93.75%	98.87%	--	--	--	--
Operating Margin	-52.67%	-3.37%	0%	-3,500%	0%	0%
Profit Margin	-42.85%	7.86%	0%	-3,400%	0%	0%
Free Cash Flow Margin	-47.32%	13.48%	0%	-4,000%	0%	0%
EBITDA	-59	-3	-67	-35	-89	-32
EBITDA Margin	-52.67%	-3.37%	0%	-3,500%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-59	-3	-67	-35	-89	-32
EBIT Margin	-52.67%	-3.37%	0%	-3,500%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

ARS Pharmaceuticals Inc (SPRY) Price

SPRY Stock Price Chart

SPRY Income

Follow-Up Questions